Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-FR
Language English French
Date Updated 2019-06-07 2019-05-25
Drug Identification Number 02440970 02440970
Brand name FETZIMA FETZIMA
Common or Proper name FETZIMA 20MG 30 CA FETZIMA 20MG 30 CA
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients LEVOMILNACIPRAN LEVOMILNACIPRAN
Strength(s) 20MG 20MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size FETZIMA 20MG 30 CA FETZIMA 20MG 30 CA
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-05-24 2019-05-24
Actual start date 2019-05-24 2019-05-24
Estimated end date 2019-06-05 2019-06-05
Actual end date 2019-06-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Potential issue with the label Disruption in manufacture of the label
Health Canada comments